Dr. Park is an Assistant Professor of Medicine at Harvard Medical School and research assistant at Boston Childrens Hospital. Dr. Parks research focuses on understanding the mechanism by which type 2 diabetes and insulin resistance develop in obesity. Dr. Park and her colleagues have identified X--]box binding protein--]1 (XBP1), a transcription factor, as a key regulator of ER stress and insulin resistance in obesity and reported a novel interaction of XBP1s with the regulatory subunits of phosphatidyl--]inositol3--]kinse (PI3K). Dr. Parks current research aims to investigate the role of bromodomain binding protein in ER stress, insulin resistance and obesity. Research Interests: The aim of my study is to understand the mechanism by which type2 diabetes and insulin resistance develop in obesity.